Literature DB >> 21903260

The effect of hydrophilic chain length and iRGD on drug delivery from poly(ε-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles.

Zhenshu Zhu1, Chen Xie, Qin Liu, Xu Zhen, Xianchuang Zheng, Wei Wu, Rutian Li, Yin Ding, Xiqun Jiang, Baorui Liu.   

Abstract

Poly(ε-caprolactone)-b-Poly(N-vinylpyrrolidone) (PCL-b-PVP) copolymers with different PVP block length were synthesized by xanthate-mediated reverse addition fragment transfer polymerization (RAFT) and the xanthate chain transfer agent on chain end was readily translated to hydroxy or aldehyde for conjugating various functional moieties, such as fluorescent dye, biotin hydrazine and tumor homing peptide iRGD. Thus, PCL-PVP nanoparticles were prepared by these functionalized PCL-b-PVP copolymers. Furthermore, paclitaxel-loaded PCL-PVP nanoparticles with satisfactory drug loading content (15%) and encapsulation efficiency (>90%) were obtained and used in vitro and in vivo antitumor examination. It was demonstrated that the length of PVP block had a significant influence on cytotoxicity, anti-BSA adsorption, circulation time, stealth behavior, biodistribution and antitumor activity for the nanoparticles. iRGD on PCL-PVP nanoparticle surface facilitated the nanoparticles to accumulate in tumor site and enhanced their penetration in tumor tissues, both of which improved the efficacy of paclitaxel-loaded nanoparticles in impeding tumor growth and prolonging the life time of H22 tumor-bearing mice.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903260     DOI: 10.1016/j.biomaterials.2011.08.072

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Targeted drug delivery using iRGD peptide for solid cancer treatment.

Authors:  Xiangsheng Liu; Jinhong Jiang; Ying Ji; Jianqin Lu; Ryan Chan; Huan Meng
Journal:  Mol Syst Des Eng       Date:  2017-08-16

2.  Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy.

Authors:  Huizi Sha; Zhengyun Zou; Kai Xin; Xinyu Bian; Xueting Cai; Wuguang Lu; Jiao Chen; Gang Chen; Leaf Huang; Andrew M Blair; Peng Cao; Baorui Liu
Journal:  J Control Release       Date:  2014-12-30       Impact factor: 9.776

3.  Characterization of new DOPC/DHPC platform for dermal applications.

Authors:  Gelen Rodríguez; Laia Rubio; Clara Barba; Carmen López-Iglesias; Alfons de la Maza; Olga López; Mercedes Cócera
Journal:  Eur Biophys J       Date:  2012-12-27       Impact factor: 1.733

Review 4.  Tumor penetrating peptides for improved drug delivery.

Authors:  Erkki Ruoslahti
Journal:  Adv Drug Deliv Rev       Date:  2016-04-01       Impact factor: 15.470

5.  Peptides as drug delivery vehicles across biological barriers.

Authors:  Debadyuti Ghosh; Xiujuan Peng; Jasmim Leal; Rashmi Mohanty
Journal:  J Pharm Investig       Date:  2017-12-12

6.  Biologically active Camellia oleifera protein nanoparticles for improving the tumor microenvironment and drug delivery.

Authors:  Xiaoping Qian; Tinghui Shen; Xiaoke Zhang; Chongzhi Wang; Weibo Cai; Rongshi Cheng; Xiqun Jiang
Journal:  Biomater Sci       Date:  2020-06-16       Impact factor: 6.843

7.  The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.

Authors:  Ke-Fu Yu; Wei-Qiang Zhang; Li-Min Luo; Ping Song; Dan Li; Ruo Du; Wei Ren; Dan Huang; Wan-Liang Lu; Xuan Zhang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2013-07-15

8.  Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models.

Authors:  Yan Zhang; Hui Zhang; Wenbin Wu; Fuhong Zhang; Shi Liu; Rui Wang; Yingchun Sun; Ti Tong; Xiabin Jing
Journal:  Int J Nanomedicine       Date:  2014-04-23

9.  Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.

Authors:  Ruo Du; Ting Zhong; Wei-Qiang Zhang; Ping Song; Wen-Ding Song; Yang Zhao; Chao Wang; Yi-Qun Tang; Xuan Zhang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2014-06-24

Review 10.  Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma.

Authors:  Min Li; Weiyue Zhang; Birong Wang; Yang Gao; Zifang Song; Qi Chang Zheng
Journal:  Int J Nanomedicine       Date:  2016-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.